Biopharmaceutical company
H.J. Res. 59, the Continuing Appropriations Resolution and debt ceiling. Issues concerning incenting antibiotic development. H.R. 3204, The Drug Quality and Security Act; The Compounding Clarity Act of 2013 and S. 959, The Pharmaceutical Quality, Security and Accountability Act as they relate to the tracking and tracing of pharmaceutical drugs. Issues related to Medicare reimbursement for new technologies.
BUD - Budget/Appropriations HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
MARY BETH SAVARY TAYLOR STACEY HUGHES EMILY PORTER STACEY HUGHES MARY BETH SAVARY TAYLOR EMILY PORTER MARY BETH SAVARY TAYLOR STACEY HUGHES EMILY PORTER